Testicular cancer before and after cisplatin: a 30-year view

被引：0

作者：

Ansell, Wendy ^{[1
]}

Shamash, Jonathan ^{[1
]}

机构：

[1] St Bartholomews Hosp, London EC1A 7BE, England

来源：

INTERNATIONAL JOURNAL OF UROLOGICAL NURSING | 2008年 / 2卷 / 03期

关键词：

Historical perspective; Multidisciplinary working; Survivorship; Testicular cancer; Testicular germ cell tumours; Treatment advances;

D O I：

10.1111/j.1749-771X.2008.00060.x

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

Exciting changes have been made in the management of testicular germ cell cancers over the past 30 years. Today, more than 80% of men who present with metastatic disease are cured compared with about 15% in the early 1970s. This means that there are a large number of survivors and many of them have willingly provided information that can be used in shaping the management of other malignancies. The paper aims to summarize the current management of testicular germ cell cancers comparing the situation in the pre-platinum era with that today and to consider current and future developments in the management of this disease.

引用

页码：103 / 112

页数：10

共 50 条

[21] Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer
Altena, R.
de Haas, E. C.
Nuver, J.
Brouwer, C. A. J.
van den Berg, M. P.
Smit, A. J.
Postma, A.
Sleijfer, D. Th
Gietema, J. A.
BRITISH JOURNAL OF CANCER, 2009, 100 (12) : 1861 - 1866
[22] A Population-Based Analysis of 30-Year Mortality among Five-Year Survivors of Adolescent and Young Adult Cancer: The Roles of Primary Cancer, Subsequent Malignancy, and Other Health Conditions
Moke, Diana J.
Song, Ziwei
Liu, Lihua
Hamilton, Ann S.
Deapen, Dennis
Freyer, David R.
CANCERS, 2021, 13 (16)
[23] Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapy
Marrit A. Tuinman
Harald J. Hoekstra
Dirk Th. Sleijfer
Joke Fleer
Damon J. Vidrine
Ellen R. Gritz
Josette E. H. M. Hoekstra-Weebers
Supportive Care in Cancer, 2007, 15 : 279 - 286
[24] Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapy
Tuinman, Marrit A.
Hoekstra, Harald J.
Sleijfer, Dirk Th.
Fleer, Joke
Vidrine, Damon J.
Gritz, Ellen R.
Hoekstra-Weebers, Josette E. H. M.
SUPPORTIVE CARE IN CANCER, 2007, 15 (03) : 279 - 286
[25] CHEMOTHERAPY OF TESTICULAR CANCER - 10-YEAR EXPERIENCE
ONDRUS, D
HORNAK, M
MATOSKA, J
KAUSITZ, J
BELAN, V
CARSKY, S
NEOPLASMA, 1993, 40 (04) : 247 - 253
[26] Testicular Cancer - Explanatory Models for high Cisplatin Chemosensibility and new Therapeutic Options
Ebbing, J.
Christoph, F.
Kempkensteffen, C.
Weikert, S.
Schostak, M.
Hinz, S.
Lein, M.
Miller, K.
Schrader, M.
AKTUELLE UROLOGIE, 2008, 39 (06) : 429 - 435
[27] Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy
Shields, Lisa B. E.
Daniels, Michael W.
Mar, Nataliya
Rezazadeh Kalebasty, Arash
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (03): : 183 - 194
[28] Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer
Bokemeyer, C
Berger, CC
Hartmann, JT
Kollmannsberger, C
Schmoll, HJ
Kuczyk, MA
Kanz, L
BRITISH JOURNAL OF CANCER, 1998, 77 (08) : 1355 - 1362
[29] Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer
Strumberg, D
Brügge, S
Korn, MW
Koeppen, S
Ranft, J
Scheibert, G
Reiners, C
Möckel, C
Seeber, S
Scheulen, ME
ANNALS OF ONCOLOGY, 2002, 13 (02) : 229 - 236
[30] Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin
Bandak, Mikkel
Jorgensen, Niels
Juul, Anders
Lauritsen, Jakob
Kier, Maria Gry Gundgaard
Mortensen, Mette Sakso
Daugaard, Gedske
EUROPEAN UROLOGY FOCUS, 2018, 4 (04): : 591 - 598

← 1 2 3 4 5 →